MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

Andere talen Medical Developments International Limited

Aandelen

MVP

AU000000MVP2

Farmaceutische producten

Vertraagde tijd Australian S.E. Andere beurzen 05:19:12 05-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,4250 ^AUD	+2,41%		+3,66%	-44,08%

13/11	Medical Developments International Limited kondigt aan dat Mary Sontrop ontslag neemt uit de Raad van Bestuur, met ingang van 20 december 2024	CI
26/08	Medical Developments International Limited, 2024 Earnings Call, Aug 26, 2024

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Medical Developments International Limited Announces Resignation of Mary Sontrop from the Board, Effective December 20, 2024	13/11
MEDICAL DEVELOPMENTS INTERNATIONAL : EXTENDS AGREEMENT FOR PENTHROX® (METHOXYFLURANE) DISTRIBUTION WITH GALEN IN UK AND IRELAND	30/10
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2024	26/08
Medical Developments International to Raise AU$10 Million via Placement, Entitlement Offer	26/07
Medical Developments International Expects Fiscal 2024 Write-Downs of AU$31 Million	12/07
Medical Developments International Limited Provides Group Write-Downs Guidance for the Year 2024	12/07
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index	18-09-23
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023	31-08-23
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Medical Developments International Limited Announces Resignation of David Williams from Board	18-04-23
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US	11-04-23
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index	20-03-23
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%	18-01-23
Medical Developments International Limited Discontinues China Clinical Trials	17-01-23
Medical Developments International Limited Provides Revenue Guidance for the Year 2023	26-09-22
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022	26-09-22
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index	19-09-22
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26-08-22
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26-08-22
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike	04-08-22
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023	04-08-22
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022	30-05-22
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited	10-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Medical Developments International Limited

Aandelen

MVP

AU000000MVP2

Farmaceutische producten

Andere talen

Filters